Over 10 years experience of Traceability Solutions
By Pharmatrax Author
Category: News
No CommentsWith the Dow Jones Industrial Average, the Nasdaq Composite Index, and the S&P 500 all down by more than 20% from their recent highs, there’s no doubt that the COVID-19 pandemic has pushed U.S. stock markets into bear territory. What’s more, the social distancing measures being used to control the spread of the SARS-CoV-2 virus have badly damaged the global economy and global supply chains and have put a number of industries, such as airlines, brick-and-mortar retailers, and sit-down restaurants, in a serious financial bind.
The good news is that this pandemic will eventually end. Several pharmaceutical companies are trialing a variety of novel therapeutics that could shorten the clinical course of the disease and perhaps lessen its severity in acute cases, leading to fewer fatalities. Moreover, numerous vaccine candidates are under development, some of which could be available for widespread use as soon as mid-2021.
Source: https://www.fool.com/investing/2020/04/05/30-top-stocks-and-funds-to-beat-the-covid-19-bear.aspx